PharVision Advisers’s NPK International NPKI Stock Holding History

PharVision Advisers’s Portfolio NPKI Stock Details NPKI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-23,980	Closed	-$286K	–	688
2025 Q4	$286K	Buy	+23,980	New	+$293K	0.14%	297

Other funds holding NPKI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PharVision Advisers's NPKI Position: Q1 2026 in Review

PharVision Advisers sold out of NPK International (NPKI) in Q1 2026, closing a stake of 23,980 shares — an estimated $286K sold.

PharVision Advisers first reported a position in NPKI in Q4 2025 and held it in 1 quarter. The position peaked at $286K in Q4 2025. 246 funds tracked by Wall St. Rank hold NPKI as of Q1 2026.

PharVision Advisers reported no remaining NPK International position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 23,980 NPK International shares in Q1 2026, an estimated $286K.
PharVision Advisers first reported a position in NPK International in Q4 2025 and held it in 1 quarter.
PharVision Advisers's NPK International position peaked at $286K in Q4 2025.
246 funds tracked by Wall St. Rank held NPK International as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.